Loading...
Transcatheter aortic valve replacement in low risk patients: a review of PARTNER 3 and Evolut low risk trials
Transcatheter aortic valve replacement (TAVR) has become a mainstay in treatment for patients with severe aortic stenosis who are considered high-risk surgical candidates. The use of TAVR in low-risk patients with severe aortic stenosis is being explored as an alternative to surgical aortic valve re...
Na minha lista:
| Udgivet i: | Cardiovasc Diagn Ther |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AME Publishing Company
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7044101/ https://ncbi.nlm.nih.gov/pubmed/32175228 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/cdt.2019.09.12 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|